Cancer-Related Fatigue as a Late Effect:

Severity in Relation to Diagnosis, Therapy, and Related Symptoms
  • Gary R. Morrow
  • Joseph A. Roscoe
  • Maralyn E. Kaufman
  • Christopher Bole
  • Colmar Figueroa-Moseley
  • Maarten Hofman
  • Karen M. Mustian
Part of the Medical Radiology book series (MEDRAD)

Abstract

Cancer-related fatigue (CRF) is widely recognized as the most distressing adverse effect experienced by cancer patients. We report on a large prospective survey conducted in part to characterize CRF severity in relation to depression and shortness of breath and to compare symptom severity in radiation and chemotherapy patients and over time. Careful characterization of CRF will aid in the development of effective methods to manage this disabling symptom.

Keywords

Symptom Severity Therapy Group Radiation Therapy Group Chemotherapy Group Fatigue Severity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ahlberg K, Ekman T, Gaston-Johansson F (2005) The experience of fatigue, other symptoms and global quality of life during radiotherapy for uterine cancer. Int J Nurs Studies 42:377–386CrossRefGoogle Scholar
  2. 2.
    Ahlberg K, Ekman T, Gaston-Johansson F et al (2003) Assessment and management of cancer-related fatigue in adults. Lancet 362:640–650PubMedCrossRefGoogle Scholar
  3. 3.
    Curt GA, Breitbart W, Cella D et al (2001) Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. In: Marty M, Pecorelli S (eds) Fatigue and cancer, 1st ed. Elsevier, Amsterdam, pp3–16Google Scholar
  4. 4.
    Irvine D, Vincent L, Graydon JE et al (1994) The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy. A comparison with the fatigue experienced by healthy individuals. Cancer Nurs 17:367–378PubMedCrossRefGoogle Scholar
  5. 5.
    Morrow GR, Andrews PL, Hickok JT et al (2002) Fatigue associated with cancer and its treatment. Support Care Cancer 10:389–398PubMedCrossRefGoogle Scholar
  6. 6.
    Morrow GR, Hickok JT, Lindke Jet al (1999) Longitudinal assessment of fatigue in consecutive chemotherapy patients: an URCC CCOP study. Proc Annual Meeting Am Soc Clin Oncol 18:593a, (Abstract No. 2293)Google Scholar
  7. 7.
    Morrow GR, Shelke AR, Roscoe JA et al (2005) Management of cancer-related fatigue. Cancer Invest 23:225–235CrossRefGoogle Scholar
  8. 8.
    Stasi R, Abriani L, Beccaglia P et al (2003) Cancer-related fatigue: evolving concepts in evaluation and treatment. Cancer 98:1786–1801PubMedCrossRefGoogle Scholar
  9. 9.
    Hickok J, Roscoe J, Morrow GR et al (2005) Frequency, severity, clinical course and correlates of fatigue in 372 patients during five weeks of radiotherapy (RT) for cancer. Cancer 104:1772–1778PubMedCrossRefGoogle Scholar
  10. 10.
    Hofman M, Morrow GR, Roscoe JA et al (2004) Cancer patients’ expectations of experiencing treatment-related side effects: an University of Rochester Cancer Center-Community Clinical Oncology Program study of 938 patients from community practices. Cancer 101:851–857PubMedCrossRefGoogle Scholar
  11. 11.
    Shields CG, Morrow GR, Griggs J et al (2004) Decision role preferences of patients receiving adjuvant cancer treatment: an University of Rochester Cancer Center Community Clinical Oncology Program. Supportive Cancer Ther 1:119–126CrossRefGoogle Scholar
  12. 12.
    Yates JS, Mustian KM, Morrow GR et al (2005) Prevalence of complimentary and alternative medicine use in cancer patients during treatment. Support Care Cancer 13:806–811PubMedCrossRefGoogle Scholar
  13. 13.
    Cleeland CS, Mendoza TR, Wang XS et al (2000) Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer 89:1634–1646PubMedCrossRefGoogle Scholar
  14. 14.
    Morrow GR, Roscoe JA, Bushunow P et al (2000) The relationship of circadian rhythm with fatigue and depression in breast cancer patients. Supportive Care Cancer 8:250Google Scholar
  15. 15.
    Vogelzang NJ, Breitbart W, Cella D et al (1997) Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Seminars Hematol 34:4–12Google Scholar
  16. 16.
    De Jong N, Candel MJJM, Schouten HC et al (2005) Course of mental fatigue and motivation in breast cancer patients receiving adjuvant chemotherapy. Annals Oncol 16:372–382CrossRefGoogle Scholar
  17. 17.
    Hann D, Winter K, Jacobsen P (1999) Measurement of depressive symptoms in cancer patients: evaluation of the Center for Epidemiological Studies Depression Scale (CES-D). J Psychosom Res 46:437–443PubMedCrossRefGoogle Scholar
  18. 18.
    Visser MR, Smets EM (1998) Fatigue, depression and quality of life in cancer patients: How are they related? Support Care Cancer 6:101–108PubMedCrossRefGoogle Scholar
  19. 19.
    Irvine DM, Vincent L, Graydon JE et al (1998) Fatigue in women with breast cancer receiving radiation therapy. Cancer Nurs 21:127–135PubMedCrossRefGoogle Scholar
  20. 20.
    Schwartz AL, Nail LM, Chen S et al (2000) Fatigue patterns observed in patients receiving chemotherapy and radiotherapy. Cancer Invest 18:11–19PubMedGoogle Scholar
  21. 21.
    Broeckel JA, Jacobsen PB, Horton J et al (1998) Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol 16:1689–1696PubMedGoogle Scholar
  22. 22.
    Loge JH, Abrahamsen AF, Kaasa S (2000) Fatigue and psychiatric morbidity among Hodgkin’s disease survivors. J Pain Symptom Management 19:91–99CrossRefGoogle Scholar
  23. 23.
    Smets EM, Visser MR, Willems-Groot AF et al (1998) Fatigue and radiotherapy: (A) experience in patients undergoing treatment. Br J Cancer 78:899–906PubMedGoogle Scholar
  24. 24.
    Scott HR, McMillan DC, Forrest LM et al (2002) The systematic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer. Br J Cancer 87:264–267PubMedCrossRefGoogle Scholar
  25. 25.
    Miaskowski C (2004) Gender differences in pain, fatigue, and depression in patients with cancer. J Natl Cancer Inst Monogr 32:139–143PubMedCrossRefGoogle Scholar
  26. 26.
    Berger A, Walker SN (2001) An explanatory model of fatigue in women receiving adjuvant breast cancer chemotherapy. Nurse Res 50:43–54Google Scholar
  27. 27.
    De Jong N, Candel MJJM, Schouten HC et al (2004) Prevalence and course of fatigue in breast cancer patients receiving adjuvant chemotherapy. Ann Oncol15:896–905PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2008

Authors and Affiliations

  • Gary R. Morrow
    • 1
  • Joseph A. Roscoe
    • 2
  • Maralyn E. Kaufman
    • 2
  • Christopher Bole
    • 2
  • Colmar Figueroa-Moseley
    • 2
  • Maarten Hofman
    • 2
  • Karen M. Mustian
    • 2
  1. 1.URCC-CCOP Research Base, Department of Radiation Oncology, James P. Wilmot Cancer CenterUniversity of Rochester School of Medicine and Dentistry, Behavioral Medicine UnitRochesterUSA
  2. 2.Department of Radiation Oncology, Behavioral Medicine Unit, James P. Wilmot Cancer CenterUniversity of Rochester School of Medicine and DentistryRochesterUSA

Personalised recommendations